Dr. Collins interview with Medscape’s Dr. Eric Topol

Posted on by admin

In an interview with Medscape, Dr. Collins discusses the Precision Medicine Initiative and its potential long-term impact on science and medicine.
SOURCE: NIH Director’s Page – Read entire story here.

Related posts:

  1. Fiscal Year 2016 Budget Request Testimony by Francis S. Collins, M.D., Ph.D. ...
  2. Dr. Collins interview with NEJM NEJM interviews Dr. Collins on what can be expected from the Precision Medicine Initiative. ...
  3. Continuing America’s Leadership in Medical Innovation for Patients Testimony by Francis S. Collins, M.D., Ph.D., before the Senate Committee on Health, Education, Labor, and Pensions on Continuing America’s Leadership in Medical Innovation for Patients. ...
  4. Statement on the National Children’s Study Dr. Collins statement on the National Children’s Study. ...
  5. Statement on USG Policy for Institutional Oversight of Life Sciences Dual Use Research of Concern Life sciences research benefits almost every aspect of our daily lives, leading to improvements in medicine, agriculture, environmental quality, and our national security. ...

Related Posts

Scientific research: Association between indoor tanning bed use and skin cancers

With May being Skin Cancer Awareness Month and in tandem with our event Wednesday co-hosted with the Congressional Families Cancer Prevention Program, The Hazards and Allure of Indoor Tanning Beds on College Campuses we are running a series on skin cancer. Be sure to check back daily for posts on skin cancer including how you prevent and detect it. Enjoy! There is mounting scientific research that shows an association between indoor tanning bed use and the risk of developing melanoma and non-melanoma skin cancers. I believe that significant public health efforts to reduce indoor tanning could greatly reduce the burden of skin cancer. I have spent the past several years developing a research program related to better understanding the decision to use indoor tanning beds

New recommendations aim to improve safety of pain-relieving spinal steroid injections

More and more people are seeking injections of anti-inflammatory steroid medications for back and neck pain. In 2011, the last year for which complete information is available, doctors pushed the plunger on 2.3 million steroid injections into the spine — and that’s just among people covered by Medicare. These injections deliver drugs that mimic the effects of two hormones, cortisone and hydrocortisone, to reduce inflammation and help relieve pain. When they work — they don’t always — such injections can bring profound relief. “If you are in severe pain with a ruptured spinal disc and you get a steroid injection, you are going to feel better sooner,” says Dr. James P. Rathmell, professor of anesthesia at Harvard Medical School. “That’s the good